Aesculap S4 Element 4.5mm Polyaxial Screws (ST240T, ST241T, ST242T, ST243T, ST244T, and ST245T). ...
FDA Device Recall #Z-2333-2012 — Class II — July 25, 2012
Recall Summary
| Recall Number | Z-2333-2012 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 25, 2012 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Aesculap Implant Systems LLC |
| Location | Center Valley, PA |
| Product Type | Devices |
| Quantity | 5 |
Product Description
Aesculap S4 Element 4.5mm Polyaxial Screws (ST240T, ST241T, ST242T, ST243T, ST244T, and ST245T). The S4 Spinal System is intended for anterior/anterolateral and posterior, non-cervical pedicle and non-pedicle fixation. Fixation is limited to skeletally mature patients and is intended to be used as an adjunct to fusion using autograft or allograft. The device is indicated for treatment of the following acute and chronic instabilities or deformities: 1 - degenerative disc disease, 2 - spondylolisthesis, 3 - trauma, 4 - spinal stenosis, 5 - deformities or curvatures, 6 - tumor, 7 - pseudoarthrosis, and 8 - failed previous fusion.
Reason for Recall
There is a possibility that the screw channel that holds the rod in place may be out of tolerance. When the depth of the channel is not deep enough, the rod may not be able to provide ample compression on the insert preventing the screw head from locking down to the bone screw.
Distribution Pattern
Nationwide Distribution-including the states of IL, MN, NV, OK, and TX.
Lot / Code Information
All distributed lots and serial numbers
Other Recalls from Aesculap Implant Systems LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2518-2023 | Class II | For intraventricular indications mainly used fo... | Jul 20, 2023 |
| Z-2146-2023 | Class II | Aesculap Surgical Needle, straight, 3 1/2", (90... | May 18, 2023 |
| Z-1569-2023 | Class II | Aesculap Caiman Articulating D5/360MM - An elec... | Mar 21, 2023 |
| Z-1430-2023 | Class II | Caspar Cervical Retractor (CCR) Basket ME754 - ... | Feb 23, 2023 |
| Z-1638-2022 | Class II | Aesculap ENNOVATE SET SCREW STERILE-implants ar... | Jul 15, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.